Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

TerminatedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

August 1, 2011

Primary Completion Date

January 30, 2016

Study Completion Date

January 30, 2016

Conditions
Breast Cancer
Trial Locations (23)

Unknown

Research Site, Beijing

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Guiyang

Research Site, Tangshan

Research Site, Harbin

Research Site, Wuhan

Research Site, Changsha

Research Site, Hohhot

Research Site, Kunshan

Research Site, Nanjing

Research Site, Nantong

Research Site, Xuzhou

Research Site, Changchun

Research Site, Qingdao

Research Site, Weifang

Research Site, Shanghai

Research Site, Chengdu

Research Site, Tianjin

Research Site, Kunming

Research Site, Hanghzou

Research Site, Hangzhou

Research Site, Zhoushan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY